Alzheimer's Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope? episode artwork

EPISODE · Jan 4, 2023 · 29 MIN

Alzheimer's Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope?

from Conversations on Health Care

Dr. Howard Fillit, the Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation, focuses the nonprofit on supporting scientists around the globe who are investigating novel drugs to prevent, treat and cure Alzheimer’s disease. He explains to hosts Mark Masselli and Margaret Flinter how those investments are paying dividends in terms of diagnostic tools and treatments and why the upcoming holidays are a perfect time to assess if a loved one is showing signs of dementia.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode metadata supplied by the publisher feed · Published Jan 4, 2023

Embed this episode

Ready to play

Alzheimer's Foundation Head Discusses Breakthroughs: Can Biomarkers & Vaccines Offer Hope?

0:00 29:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Conversations on Health Care?

This episode is 29 minutes long.

When was this Conversations on Health Care episode published?

This episode was published on January 4, 2023.

Can I download this Conversations on Health Care episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!